prof. Peter Hellings

Nouveau dispositif pour les tests cutanés : validation du seuil du Skin Prick Automated Test (SPAT) chez des patients allergiques au pollen de bouleau et aux acariens

S.F. Seys, A. Gherasim, F.O.C. Odul, Z. Diamant, Philippe Gevaert (UGent) , Peter Hellings (UGent) , D. Loeckx, S. Gorris and D.B. Frederic

(2025) REVUE FRANÇAISE D'ALLERGOLOGIE. In Revue Française d'Allergologie 65(Supplement). p.3-3

Add to list

Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST) : a multicentre, randomised, double-blind, head-to-head phase 4 trial

Eugenio De Corso, G Walter Canonica, Enrico Heffler, Michal Springer, Tomasz Grzegorzek, Miguel Viana, Zsuzsanna Horváth, Joaquim Mullol, Philippe Gevaert (UGent) , Justin Michel, et al.

(2025) LANCET RESPIRATORY MEDICINE. 13(12). p.1067-1077

Add to list

Journal Article
A2
open access

EUFOREA meeting on defining disease states in allergic rhinitis : towards a unified language in AR

G. K. Scadding, D. M. Conti, Sophie Scheire (UGent) , V. Backer, M. Blaiss, L. O. Cardell, W. De Yun, A. K. Ellis, W. Fokkens, A. T. Fox, et al.

(2025) FRONTIERS IN ALLERGY. 5.

Add to list

Journal Article
A2
open access

Raising the bar in respiratory care by EUFOREA : report of the European Union Parliament Symposium, April 2024

Peter Hellings (UGent) , D. M. Conti, X. Bertels, V. Backer, Guy Brusselle (UGent) , E. De Corso, W. J. Fokkens, A. T. Fox, Philippe Gevaert (UGent) , S. Lau, et al.

(2025) FRONTIERS IN ALLERGY. 6.

Add to list

Validation of the skin prick automated test (SPAT) cut‐off value in birch pollen and house dust mite allergic rhinitis patients

Sven F. Seys, Alina Gherasim, Florian Odul, Frank Dietsch, Zuzana Diamant, Philippe Gevaert (UGent) , Peter Hellings (UGent) , Dirk Loeckx, Senne Gorris and Frédéric de Blay

(2025) ALLERGY. 80(12). p.3302-3309

Add to list

Improved allergy wheal detection for the skin prick automated test device

Rembert Daems (UGent) , Sven Seys, Valérie Hox, Adam Chaker, Glynnis De Greve, Winde Lemmens, Anne-Lise Poirrier, Eline Beckers, Zuzana Diamant, Carmen Dierickx, et al.

(2025) ARTIFICIAL INTELLIGENCE IN MEDICINE, AIME 2025, PT II. In Lecture Notes in Computer Science 15735. p.116-120

Add to list

EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP

W J Fokkens, E De Corso, V Backer, M Bernal-Sprekelsen, L Bjermer, C von Buchwald, A Chaker, Z Diamant, Philippe Gevaert (UGent) , J Han, et al.

(2024) RHINOLOGY. 62(3). p.287-298

Add to list

Journal Article
A2
open access

European biologic training course for type 2 inflammation by EUFOREA in 2024 : key facts and lessons learned

D. M. Conti, V. Backer, W. Fokkens, Philippe Gevaert (UGent) , A. Peters, G. K. Scadding, I. Pavord, S. Lau, M. Wechsler, X. Bertels, et al.

(2024) FRONTIERS IN ALLERGY. 5.

Add to list

Journal Article
A1
open access

Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP

Claus Bachert (UGent) , Asif H. Khan, Wytske J. Fokkens, Claire Hopkins, Philippe Gevaert (UGent) , Joseph K. Han, Peter Hellings (UGent) , Stella E. Lee, Jérôme Msihid, Scott Nash, et al.

(2024) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 154(6). p.1442-1449

Add to list

Journal Article
A1
open access

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up

Martin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, Peter Hellings (UGent) , Joseph K. Han, Anju T. Peters, Jared Silver, Steven G. Smith, Abigail Fuller, Ana R. Sousa, et al.

(2024) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 14(1). p.18-31

Academic Bibliography

prof. Peter Hellings

Nouveau dispositif pour les tests cutanés : validation du seuil du Skin Prick Automated Test (SPAT) chez des patients allergiques au pollen de bouleau et aux acariens

Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST) : a multicentre, randomised, double-blind, head-to-head phase 4 trial

EUFOREA meeting on defining disease states in allergic rhinitis : towards a unified language in AR

Raising the bar in respiratory care by EUFOREA : report of the European Union Parliament Symposium, April 2024

Validation of the skin prick automated test (SPAT) cut‐off value in birch pollen and house dust mite allergic rhinitis patients

Improved allergy wheal detection for the skin prick automated test device

EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP

European biologic training course for type 2 inflammation by EUFOREA in 2024 : key facts and lessons learned

Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up

Contents

Support

Contact